Pharmacel® sMCC 90
Microcrystalline Cellulose 101
Microcrystalline Cellulose
Highly Consistent Excipient
Strong Binder For Wet And Dry Granulation
Specifications
| Density | Tapped density | 440 g/l |
| Bulk density | 280 g/l | |
| Particle size | D10 | 25 μm |
| D50 | 60 μm | |
| D90 | 120 μm | |
| Hausner ratio | 1,57 | |
|
Production site |
Nagpur, Cuddalore, India | |
| Conforms to USP-NF, Ph.Eur., JP, IP | ||
Expected delivery within 5-7 days. Each order ships with Certificate of Analysis, Material Safety Data Sheet and Product Data Sheet.
Pharmacel® 101 Microcrystalline cellulose (MCC) has been developed specifically as a key component for wet granulation and dry granulation formulations. DFE Pharma offers Pharmacel® 101 from two high quality production sites.
Fast delivery
Halal and kosher certificates
Best Pharmaceutical grade lactose
Small quantities
Additional information
Pharmacel® sMCC 90, a silicified microcrystalline cellulose, developed as the synergistic solution for challenging oral solid dosage formulations. Co-processing microcrystalline cellulose with silicon dioxide increases its surface area, resulting in enhanced powder flow, superior tabletability, and improved formulation robustness.
Pharmacel® sMCC 90 benefits
This new addition to our well-established excipients’ portfolio offers customers worldwide the highest quality excipients and services. Pharmacel® sMCC 90 has the following benefits compared to conventional excipients:
- Improved tablet compression
- Higher production speeds
- Rapid formulation development
Improved tablet compression
Pharmacel® sMCC 90 is a highly functional excipient for direct compression processes. In comparison with conventional excipients, Pharmacel® sMCC 90 leads to lower capping of tablets at high compaction speed thereby enabling 20% harder tablets.
Higher production speeds
The production speed of tablets depends on the pace of several intermittent steps. Pharmacel® sMCC 90 enables higher processing speed in n multiple units of operation. Additionally, Pharmacel® sMCC 90 allows for a swift and more consistent flow from the hopper.
The flowability of Pharmacel® sMCC 90 enables consistency in tablet weight, with weight variation below 1% for 250mg placebo tablets.
Rapid formulation development
Pharmacel® sMCC 90 mitigates formulation challenges due to its improved flow and compaction compared to conventional excipients. Additionally, low lubricant and dwell-time sensitivity allow for easy-scale up. Moreover, Pharmacel® sMCC 90 reduces the number of excipients compared to regular grades and removes the need to process
Document Overview
Because our PDF QAR documents are technically certified, you may experience difficulties when opening them in a browser. Save the PDF file first and then open the PDF file in a standard PDF reader (e.g. Adobe Reader)
On
Off
Show all description
Product specifications
Show description Hide description
Technical papers
Show description Hide description
Product sheets
Show description Hide description
Brochure
Show description Hide description
Contaminants
Show description Hide description
Ingredient Declaration
Show description Hide description
Show description Hide description
MSDS
Show description Hide description
Nutritional
Show description Hide description
Other quality and regulatory documents
Show description Hide description
Show description Hide description
Show description Hide description
Show description Hide description
Show description Hide description
Show description Hide description
Show description Hide description
Show description Hide description
Show description Hide description
Show description Hide description
Show description Hide description
Show description Hide description
Show description Hide description
Show description Hide description
Show description Hide description
Shelf life
Show description Hide description
ALBA
Show description Hide description